Drug intelligence / Profile preview

Pyrodace Forte

Development stage
Unknown
Lead developer
PlasoRon Biotech
Modality
Small Molecules
Administration
Oral
01

Overview

Pyrodace Forte is an oral combination supplement containing N-acetylcysteine (600 mg) and pyridoxamine (or pyridoxine, 50 mg), marketed primarily in India by Plasoron Biotech. It is used to support kidney function and slow the progression of chronic kidney disease (CKD) and diabetic kidney disease. N-acetylcysteine acts as a precursor to glutathione, replenishing cellular antioxidant stores and protecting kidney tissues from oxidative stress and damage, including contrast-induced kidney injury. Pyridoxamine (or pyridoxine) is a form of Vitamin B6 that serves as a cofactor in metabolic pathways, helping to regulate the metabolism of proteins, carbohydrates, and lipids, and assisting in maintaining energy balance in patients with renal impairment.

Brand names
Pyrodace Forte
Other names
N-acetylcysteine + pyridoxamineN-acetylcysteine + pyridoxamine dihydrochlorideN-acetylcysteine + pyridoxineN-acetylcysteine + pyridoxine hydrochlorideacetylcysteine + pyridoxamineacetylcysteine + pyridoxamine dihydrochlorideacetylcysteine + pyridoxineacetylcysteine + pyridoxine hydrochloride
02

Targets

PDXK (Pyridoxal kinase)PNPO (Pyridoxine 5'-phosphate oxidase)

Beyond the preview

Go deeper on Pyrodace Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyrodace Forte.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call